Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Butman

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Developments in Biologicals|March 29, 2006
Comprehensive characterization of the 293-ORF6 cell lineB T Butman, A Lizonova, D E Brough, et al.
Clinical Chemistry|July 1, 1993
Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassayW C Taddei-Peters, B T Butman, G R Jones, et al.
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Clinical Chemistry|April 1, 1993
Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assayM J Hursting, B T Butman, J P Steiner, et al.
Stroke|October 1, 1995
Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular diseaseG Jürgens, W C Taddei-Peters, P Költringer, et al.
The Journal of Urology|September 1, 1997
A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancerB S Schmetter, K K Habicht, D L Lamm, et al.
Developments in Biologicals|August 15, 2012
Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testingD A Brake, M McIlhaney, T Miller, et al.
Transboundary and Emerging Diseases|October 28, 2017
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattleJ Barrera, D A Brake, B J Kamicker, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Developments in Biologicals|March 29, 2006
Comprehensive characterization of the 293-ORF6 cell lineB T Butman, A Lizonova, D E Brough, et al.
Clinical Chemistry|July 1, 1993
Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassayW C Taddei-Peters, B T Butman, G R Jones, et al.
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Clinical Chemistry|April 1, 1993
Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assayM J Hursting, B T Butman, J P Steiner, et al.
Stroke|October 1, 1995
Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular diseaseG Jürgens, W C Taddei-Peters, P Költringer, et al.
The Journal of Urology|September 1, 1997
A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancerB S Schmetter, K K Habicht, D L Lamm, et al.
Developments in Biologicals|August 15, 2012
Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testingD A Brake, M McIlhaney, T Miller, et al.
Transboundary and Emerging Diseases|October 28, 2017
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattleJ Barrera, D A Brake, B J Kamicker, et al.
Pageof 2